[Long-acting beta2-agonist bronchodilators safety for asthma treatment].
Giubergia
Verónica
V
Servicio de Neumonología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina. vgiubergia@garrahan.gov.ar
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004983:Ethanolamines / Q000627:therapeutic use*; D000068759:Formoterol Fumarate; D006801:Humans; D000068299:Salmeterol Xinafoate
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations; D004983:Ethanolamines; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000068759:Formoterol Fumarate